Vimarsana
Biggest News Aggregation in the World

Caley Castelein News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Caley Castelein. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Caley Castelein Today - Breaking & Trending Today

Tourmaline Bio (NASDAQ:TRML) Shares Gap Up to $36.01 - Vimarsana News

Tourmaline Bio (NASDAQ:TRML) Shares Gap Up to $36.01

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $36.01, but opened at $37.60. Tourmaline Bio shares last traded at $37.47, with a volume of 329,462 shares traded. Wall Street Analysts Forecast Growth TRML has been the subject of a […]

Tourmaline Bio (NASDAQ:TRML) Reaches New 52-Week High at $35.37 - Vimarsana News

Tourmaline Bio (NASDAQ:TRML) Reaches New 52-Week High at $35.37

Tourmaline Bio, Inc. (NASDAQ:TRML – Get Free Report) hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $35.37 and last traded at $35.30, with a volume of 16661 shares changing hands. The stock had previously closed at $34.57. Wall Street Analysts Forecast Growth A number of brokerages […]

Tourmaline Bio (NASDAQ:TRML) Given "Outperform" Rating at Leerink Partnrs - Vimarsana News

Tourmaline Bio (NASDAQ:TRML) Given "Outperform" Rating at Leerink Partnrs

Leerink Partnrs reiterated their outperform rating on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research report released on Thursday, PriceTargets.com reports. Leerink Partnrs also issued estimates for Tourmaline Bio’s FY2026 earnings at ($4.00) EPS. A number of other research firms also recently weighed in on TRML. HC Wainwright reaffirmed a buy rating […]

Analysts Issue Forecasts for Tourmaline Bio, Inc.'s FY2026 Earnings (NASDAQ:TRML) - Vimarsana News

Analysts Issue Forecasts for Tourmaline Bio, Inc.'s FY2026 Earnings (NASDAQ:TRML)

Tourmaline Bio, Inc. (NASDAQ:TRML – Free Report) – Analysts at Leerink Partnrs issued their FY2026 earnings per share (EPS) estimates for Tourmaline Bio in a research note issued to investors on Thursday, December 7th. Leerink Partnrs analyst T. Smith expects that the company will post earnings of ($4.00) per share for the year. Leerink Partnrs […]

Source: wkrb13.com
Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from Analysts at Truist Financial - Vimarsana News

Tourmaline Bio (NASDAQ:TRML) Earns Buy Rating from Analysts at Truist Financial

Truist Financial initiated coverage on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a research note issued to investors on Friday morning, MarketBeat reports. The firm issued a buy rating and a $43.00 target price on the stock. TRML has been the topic of several other reports. Piper Sandler assumed coverage on shares of […]

Source: wkrb13.com